Infinity Holdings Group made an open offer to buy 26 per cent stake in the company at a price of Rs 235 per share
The company clarified that Enforcement Directorate (ED) investigation did not pertain to the company and has no bearing on the business and operations of the company.
Even if OMCs are not made to share any under-recovery, the continued pricing intervention would make it utterly difficult to divest government's stake in BPCL, Motilal Oswal said in its report
Canceled auctions and a dovish central bank decision drove benchmark yields down by more than 20 basis points in the past two weeks.
The stock hit a new low of Rs 1,218.80, down 8 per cent in the intra-day trade
Panacea Biotec may see some action on plans to launch a comprehensive coronavirus vaccine in association with THSTI.
The stock of Axis Bank underwent some profit booking and almost retested that breakout zone
LIC has not paid any dividends in nearly three years, something that may have helped shore up the insurer's net worth ahead of its IPO. More on that in our top headlines.
The Russia-Ukraine standoff is keeping investors on their toes. Business Standard's Puneet Wadhwa caught up with R Venkataraman, chairman, IIFL Securities to know if the markets' bottom is near
Higher interest rates and stiff competition could further weigh on their share prices
Technical charts suggest the bulls are not ready to give up just yet. Markets can find support at lower levels and move up, provided the news flow does not turn too adverse
Market regulator had fined lender Rs 1 cr for flouting directions in an interim order dated October 7, 2019; also directed bank to deposit Rs 159 cr along with 7% interest
Its net profit jumped 101% to Rs 3,447 crore in Dec 2021 and net sales rose 69%
RIL has already spent $1.4 billion to acquire technologies across the solar battery and hydrogen ecosystems
The CBI has questioned former National Stock Exchange group operating officer Anand Subramanian in connection with its ongoing probe into alleged irregularities by a stock broker
Closing Bell: Hindalco, UPL, Sun Pharma, Adani Ports, Divis Labs, and TCS were the top drags, down up to 3.45 per cent
Analysts anticipate a faster recovery in the demand environment and are hopeful that consumption will reach normalised pre-Covid levels in H1FY23
The stock has fallen 12 per cent from its listing day high of Rs 993 on February 16, 2022. Currently, it is trading just 1 per cent higher over its issue price of Rs 866 per share.
TCS on January 12, 2022 had approved to buyback up to 40 million equity shares of face value of Rs 1 each at Rs 4,500 per equity share for an aggregate amount of upto Rs 18,000 crore.
While new investors should benefit from the potential future growth in the company's share price, a gradual reduction of my stake should also allow me to benefit from some of the upside, GangwaL said.